Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 97365 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 122073 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 156895 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 157961 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 160020 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 166801 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 174039 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 181227 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 186023 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 190720 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 198953 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 205871 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 208323 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 209473 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 210472 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 217300 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 227531 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 232056 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 239502 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 241932 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 246811 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 254328 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 266977 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 275845 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 279820 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LINOLEIC ACID (M-H)- | 383170 | Peak area normalized | female | Pre-diabetic | Neuropathy |